Very interesting guys, I see the best way to compare the 2 is to look at MC before results were out FDA approved. DNDN were in rough terms $2-3 2009 and now 5.5bil at sp=$38 would give MC 0.29-0.430bil at this level/point in time. GIven parity with ex rate
SO we should get as high as 36-54c in aus. = $11-$16.2 on NASDAQ
HOWEVER this could be way undervalued since back then no one knew it was possible to get FDA approval!!!!!!!
AND
Prima has more products to sell
I could revise this based on prostate to ovarian market size. Has anyone got these figures?
comparison with dendreon - sp acceleration, page-7
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.020(6.90%) |
Mkt cap ! $392.7M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.0¢ | $569.8K | 2.076M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 706076 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |